15 June 2016
BENEO secures 2nd authorised 13.5 health claim in 2016 for its chicory root fibres
Inulin and oligofructose contribute to a reduction in blood glucose rise
Starting 20 June, customers working with Orafti® Inulin or Oligofructose can launch products with the following attractive claims: “Lower and more balanced blood glucose rise” or “lower impact on blood glucose levels” in combination with the official EU 13.5.health claim.
The official claim wording is as follows: "Consumption of [e.g. breakfast cereals] containing inulin and oligofructose instead of sugars induces a lower blood glucose rise after their consumption compared to sugar-containing [e.g. breakfast cereals]."
This succeeds BENEO’s first 13.5 health claim on digestive health for its chicory inulin which came into force at the beginning of the year. The recent health claim confirms that inulin and oligofructose contribute to a better blood glucose management as they support a lower rise in blood glucose response.
A 30% sugars reduction needs to be obtained by replacement by non-digestible carbohydrates such as BENEO’s inulin and oligofructose according to the conditions of use. The authorisation is based on several scientific studies all of which confirm that oligofructose and inulin have a significant part to play in the area of glycaemic control.
About 422 million people worldwide have diabetes, a number that is likely to more than double over the next 20 years. More than 90% of these people suffer from diabetes type II so preventative measures, such as healthy eating, are a key area of concern. Leading scientists agree that a low glycaemic diet reduces the risk of type II diabetes and helps to control blood glucose levels, a factor that is particularly important for people who already suffer from diabetes. Consumer awareness around the issue is growing and as a result, many more consumers are now seeking out low glycaemic products. The new health claim supports them in more easily identifying the respective products and also helps manufacturers to develop a greater variety of low glycaemic choices in response to this consumer need.
BENEO’s inulin and oligofructose, derived from chicory root, contribute to a lower glycaemic response of food and drink products because they are not digested in the human digestive system and thus no glucose is released into the blood stream. Replacing high glycaemic ingredients (e.g. sucrose, glucose, maltodextrin) using BENEO’s dietary fibres, which do not cause a glycaemic response, consequently lowers the blood glucose response of the final product and adds a valuable fibre source at the same time.
Anke Sentko, VP Regulatory Affairs and Nutrition Communication at BENEO: "Blood glucose management is a key element in the promotion of long-term health from early on. Consumers are increasingly aware that carbohydrate-based, low glycaemic products contribute to healthy nutrition. The new health claim for BENEO’s dietary fibres inulin and oligofructose confirms once again the strong scientific evidence behind our ingredients. But, even more important than that, it offers manufacturers the opportunity to help consumers make better choices in their daily diet that
support a low glycaemic nutrition."
Exclusive 13.5 digestive health claim on Orafti® Inulin
Customers working with Orafti® Inulin can launch products with a claim on pack promoting digestive health. The 13.5 health claim came into effect as of 1 January 2016.
The official wording for the claim is “chicory inulin contributes to normal bowel function by increasing stool frequency”. In addition general health-related well-being claims under article 10.3 are also possible. Amongst others, these include “chicory inulin promotes digestive health” or “chicory root fibre supports a healthy and balanced digestive system”.
With the health claim for BENEO’s chicory inulin improving bowel function, food manufacturers are well set to make the most of the ever growing consumer trend of digestive health.